Form 4 for TAK TAKEDA PHARMACEUTICAL CO LTD
Accepted 2026-09-03 21:49:19 ET · period of report 2026-09-02 · accession 0001395064-26-000335 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TI | 2026-09-03 21:49 | 2026-09-02 | TAK | Plump Andrew Stewart | Pres, R, D, Dir | S - Sale | $18.49 | -116.2K | 145.5K | -44% | -$2.15M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2026-09-02 | S | D | 116,191 | $18.49 | 145,465 | I By Trust | — | — | (F1) The sales reported herein were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026. |